Skip to main content
. 2023 Mar 20;2023(3):CD008721. doi: 10.1002/14651858.CD008721.pub3

2.1. Analysis.

2.1

Comparison 2: Analysis stratified by severity of the disease: anti‐VEGF with or without PRP versus PRP, Outcome 1: Visual acuity stratified by severity of retinopathy